Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Medication-related osteonecrosis of the jaws"'
Publikováno v:
Diagnostics, Vol 14, Iss 16, p 1700 (2024)
Medication-related osteonecrosis of the jaw (MRONJ) is a debilitating condition associated with antiresorptive and antiangiogenic medications that are frequently used in treating osteoporosis and cancers. With the ability to produce high-resolution i
Externí odkaz:
https://doaj.org/article/a71e4ca5febd4d6f8578fa92ee025cb0
Autor:
Reem Hanna, Ioana Cristina Miron, Snehal Dalvi, Praveen Arany, René Jean Bensadoun, Stefano Benedicenti
Publikováno v:
Pharmaceuticals, Vol 17, Iss 8, p 1011 (2024)
Medication-related osteonecrosis of the jaw (MRONJ) is a debilitating adverse effect of bisphosphates, antiresorptive therapy or antiangiogenic agents that can potentially increase oxidative stress, leading to progressive osteonecrosis of the jaws. D
Externí odkaz:
https://doaj.org/article/7c0accd26adf45a7bef040884018308d
Publikováno v:
Maxillofacial Plastic and Reconstructive Surgery, Vol 44, Iss 1, Pp 1-8 (2022)
Abstract Background Complications from osteoradionecrosis (ORN) and medication-related osteonecrosis of the jaw (MRONJ) include oro-cutaneous fistulas, necrotic bone exposure, soft-tissue defects, and pathologic fractures. The fibula free flap (FFF)
Externí odkaz:
https://doaj.org/article/ba93c059d6f74fce989cfe4cb50dbb97
Autor:
Suad Aljohani
Publikováno v:
Saudi Pharmaceutical Journal, Vol 31, Iss 9, Pp 101707- (2023)
Osteoporosis is the most common indication for antiresorptive drugs (ARDs). Medication-related osteonecrosis of the jaw (MRONJ) is a severe complication of ARDs. Multiple risk factors can increase the risk of MRONJ, one of which is the duration of AR
Externí odkaz:
https://doaj.org/article/4d2e6bfe69f34015bffae312fb10205c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ling-Ying Wei, Sang-Heng Kok, Yen-Ching Lee, Wei-Yih Chiu, Jai-Jen Wang, Shih-Jung Cheng, Hao-Hueng Chang, Jang-Jaer Lee
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 8, Pp 1572-1580 (2021)
Background/purpose: Anti-resorptive agents are commonly used in cancer patients with bone metastasis or multiple myeloma (MM). An adverse event termed medication-related osteonecrosis of the jaws (MRONJ) was discovered in patients using these agents
Externí odkaz:
https://doaj.org/article/044a512bec4e4532823617ca6218d321
Publikováno v:
BMC Oral Health, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Multiple myeloma (MM) constitutes approximately 10% of hematological malignancies. Bisphosphonates have established themselves in solid organ metastasis and multiple myeloma lytic bone lesions by inhibiting osteoclast activation.
Externí odkaz:
https://doaj.org/article/1e5017b411e64eebb78e73255e20e88d
Autor:
Elena Calabria, Alessandro Antonelli, Selene Barone, Daniela Adamo, Marianna Salviati, Maria Giulia Cerra, Francesco Bennardo, Amerigo Giudice
Publikováno v:
Dentistry Journal, Vol 11, Iss 6, p 147 (2023)
In the present case–control study, the impact of medication-related osteonecrosis of the jaws (MRONJ) on patients’ oral health-related quality of life (OHRQoL), overall quality of life (QoL), and psychological status was evaluated using a set of
Externí odkaz:
https://doaj.org/article/92ec2cad975e4d5da1218913ec8aa789
Publikováno v:
Clinical Interventions in Aging, Vol Volume 14, Pp 797-804 (2019)
Ji-Youn Kim,1 Hyun Chul Song,1 Hyeon-Gun Jee21Division of Oral & Maxillofacial Surgery, Department of Dentistry, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea; 2Healthcare Innovation Park, S
Externí odkaz:
https://doaj.org/article/df13e04e3ff44be7b4ca916095c9fc75